Cargando…
Neonatal Abstinence Syndrome in Infants with Prenatal Exposure to Methadone versus Buprenorphine
Neonatal abstinence syndrome (NAS) has been of increasing concern. Studies suggest that prenatal exposure to buprenorphine may be preferred to methadone in regard to neonatal withdrawal. Our aim was to determine whether the incidence and severity of NAS are different between babies prenatally expose...
Autores principales: | Kushnir, Alla, Bhavsar, Ravi, Hanna, Emad, Hegyi, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297113/ https://www.ncbi.nlm.nih.gov/pubmed/37371262 http://dx.doi.org/10.3390/children10061030 |
Ejemplares similares
-
Buprenorphine pharmacotherapy for the management of neonatal abstinence syndrome in methadone‐exposed neonates
por: Taleghani, Afshin A., et al.
Publicado: (2019) -
Prenatal Buprenorphine/Naloxone or Methadone Use on Neonatal Outcomes in Michigan
por: Goshgarian, Gregory, et al.
Publicado: (2022) -
Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone
por: Gawronski, Kristen M, et al.
Publicado: (2014) -
Use of Phenobarbital to Treat Neonatal Abstinence Syndrome From Exposure to Single vs. Multiple Substances
por: Kushnir, Alla, et al.
Publicado: (2022) -
'Diversion’ of methadone or buprenorphine: 'harm’ versus 'helping’
por: Havnes, Ingrid Amalia, et al.
Publicado: (2013)